All In MedTech

Device Trial Radar · NCT04881162

Feasibility Study of the Treatment of Acute Ischemic Stroke Using the NOVIS Transcarotid Neuroprotection System

Feasibility Study of the Treatment of Acute Ischemic Stroke Using the NOVIS Transcarotid Neuroprotection System In Transcarotid Embolectomy

Last checked: Nov 21, 2026Latest source record: Jan 17, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

12

Actual

Start

Nov 2, 2021

Primary completion

Dec 11, 2023

Study completion Dec 11, 2023

Sponsor

Lead sponsor
Silk Road MedicalNot on our public-company list
Sponsor type
Industry
First posted
May 11, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Study Objective is to establish the feasibility and safety of the NOVIS Transcarotid Neuroprotection System when used for the transcarotid intervention of patients that have a failed transfemoral endovascular therapy in the case of anterior circulation strokes due to large vessel embolic occlusions.

Conditions

  • Acute Ischemic Stroke

Interventions

  • NOVIS Transcarotid Neuroprotection System (NPS)Device

    The NOVIS Transcarotid Neuroprotection System (NPS) is intended to provide transcarotid vascular access and embolic protection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Device-related Serious Adverse EventsTime frame: 90 Days

2 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Yale University

    New Haven, Connecticut

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.